Dr. Mike Zandi trained in medical and veterinary sciences Tripos at Clare College Cambridge (part II in Experimental Psychology with Prof Barry Everitt), clinical medicine at Cambridge with elective as externe in neurology at the Salpêtrière, Paris with Bertrand Fontaine, then general medical training to MRCP(UK), neurology training in Cambridge, Norwich and London, as part of an Eastern Region Neuroscience Training Fellowship.
He carried out his PhD at Cambridge University in biomarkers of neuropsychiatric lupus and NMDAR encephalitis, with time in the laboratory of Professor Angela Vincent at Oxford University. Elected FRCP Jun 2018. Dr. Zandi has received funding support from the UCLH/UCL Biomedical Research Centre and has also received funding from the National Brain Appeal.
He is a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London and Honorary Associate Professor in the University College London Queen Square Institute of Neurology Department of Neuroinflammation. Dr. Zandi runs autoimmune encephalitis and neuroimmunology clinics, and co-chair the weekly UCL Queen Square National Hospital COVID-19 neurology and encephalitis meeting. He also sees patients with symptoms related to systemic lupus erythematosus, and neurological infection, including symptoms after Covid, which received funding support from the National Brain Appeal Charity.
Dr. Zandi is a chief investigator on the UCL Neuroimmunology 1.4 study observational study, and PI on the MRC funded SINAPPS2 trial, UKRI funded COVID CNS study, investigator on the NIHR funded STIMULATE-ICP long covid study. He has provided input on NICE guidance for long covid and input into NHS England policy on Covid treatment in neurology patients with the ABN. He is secretary and on occasion acting chair of the Queen Square Medical Committee, and co-editor of the upcoming third edition of the Queen Square Textbook of Neurology.
